You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

sqNSCLC

Showing 1 - 15 of 15
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Squamous Non-Small Cell Lung Carcinoma Trial in Chicago (Cabozantinib 40 MG, Pembrolizumab 200mg)

Recruiting
  • Metastatic Squamous Non-Small Cell Lung Carcinoma
  • Cabozantinib 40 MG
  • Pembrolizumab 200mg
  • Chicago, Illinois
    University of Illinois at Chicago
Jan 20, 2023

Squamous Non-small-cell Lung Cancer Trial in Guangzhou (HLX10+chemo, HLX10+HLX07+chemo, HLX10+HLX07)

Recruiting
  • Squamous Non-small-cell Lung Cancer
  • Guangzhou, Guangdong, China
    Guangdong Provincial People's Hospital
May 5, 2022

NSCLC, Squamous Non-small-cell Lung Cancer, Squamous Non-Small Cell Tumor of Lung Trial in United States (sapanisertib)

Recruiting
  • Non-Small Cell Lung Cancer
  • +3 more
  • Davis, California
  • +13 more
Nov 7, 2022

NSCLC Trial in Worldwide (Nivolumab)

Completed
Has Results
  • Non-Small Cell Lung Cancer
  • Wels, Oberösterreich, Austria
  • +89 more
Oct 17, 2022

Squamous-Cell Non-Small-Cell Lung Cancer Trial in Worldwide (Bemarituzumab, Docetaxel)

Recruiting
  • Squamous-Cell Non-Small-Cell Lung Cancer
  • Orange, California
  • +24 more
Jul 27, 2022

Squamous NSCLC, Non-squamous NSCLC Trial in Brazil, Canada (Nivolumab)

No longer available
  • Squamous Non-Small Cell Lung Cancer
  • Non-squamous Non-Small Cell Lung Cancer
  • Salvador, Bahia, Brazil
  • +49 more
Nov 25, 2020

Lung Cancer, NSCLC, Pulmonary Tumor Trial in Germany (ERDAFITINIB)

Unknown status
  • Lung Cancer
  • +4 more
  • Gauting, Bavaria, Germany
  • +10 more
Nov 11, 2020

Advanced Castrate-resistant Prostate Cancer CRPC, Squamous NSCLC sqNSCLC, Triple Negative Breast Cancer TNBC Trial in Worldwide

Completed
  • Advanced Castrate-resistant Prostate Cancer CRPC
  • +2 more
  • Part A: AZD8186 monotherapy
  • +5 more
  • Boston, Massachusetts
  • +12 more
May 28, 2020

Tumors Trial in Worldwide (CC-90011, Nivolumab)

Active, not recruiting
  • Neoplasms
  • Augusta, Georgia
  • +77 more
Nov 8, 2022

Metastatic Pancreatic Cancer, Colorectal Cancer, Esophageal Tumors Trial in Japan, United States (TAK-931)

Completed
Has Results
  • Metastatic Pancreatic Cancer
  • +3 more
  • Denver, Colorado
  • +9 more
Aug 24, 2021

Advanced or Metastatic Squamous NSCLC Trial in Sydney (HMBD-001, Docetaxel, Cetuximab)

Not yet recruiting
  • Advanced or Metastatic Squamous Non-Small Cell Lung Cancer
  • Sydney, New South Wales, Australia
    GenesisCare North Shore
Jun 20, 2023

Locally Advanced or Metastatic Solid Tumors, Squamous-cell NSCLC Trial in Shanghai, Xuzhou (HLX35)

Recruiting
  • Locally Advanced or Metastatic Solid Tumors
  • Squamous-cell Non-small Cell Lung Cancer
  • Shanghai, China
  • +1 more
Jun 28, 2022

NSCLC Stage IV Trial (HLX26, Serplulimab, Pemetrexed)

Not yet recruiting
  • NSCLC Stage IV
  • (no location specified)
Mar 15, 2023

Metastatic Melanoma, Lung Cancer, Renal Cancer, Squamous Cell

Withdrawn
  • Multiple Indications Cancer
  • Non-Interventional
  • Mexico, Distrito Federal, Mexico
    Local Institution
May 25, 2022

Tumors Trial in Worldwide (Rogaratinib (BAY1163877) oral solution, Rogaratinib (BAY1163877) oral tablet, Rogaratinib

Completed
Has Results
  • Neoplasms
  • Rogaratinib (BAY1163877) oral solution
  • +2 more
  • Chicago, Illinois
  • +28 more
Apr 12, 2021